Literature DB >> 14691167

Effects of TGF-beta2 in perfused human eyes.

Johannes Gottanka1, Darren Chan, Michael Eichhorn, Elke Lütjen-Drecoll, C Ross Ethier.   

Abstract

PURPOSE: TGF-beta2 is known to be present at elevated levels in the aqueous humor of patients with primary open-angle glaucoma (POAG). Studies have shown that TGF-beta2 influences cultured trabecular meshwork (TM) cells, but the effects of this cytokine on intact TM and outflow facility have not been studied. The purpose of this study was to investigate whether TGF-beta2 treatment induces changes in outflow facility and morphologic changes in the TM tissue and whether these changes are comparable to those previously recorded in glaucomatous eyes.
METHODS: Baseline facility was measured in paired human eyes (n = 8 pairs), with a constant-flow anterior segment culture system. Medium perfusing experimental eyes was then supplemented with activated human recombinant TGF-beta2 (3.0 ng/mL, comparable to or slightly greater than measured aqueous humor levels in patients with POAG), and facility was measured for at least 8 days. At the conclusion of the perfusion, eyes were fixed and processed for light microscopy, transmission electron microscopy, and immunolabeling studies.
RESULTS: TGF-beta2 perfusion reduced outflow facility by 27% (P = 0.03) and promoted focal accumulation of fine fibrillar extracellular material in multilayered structures under the inner wall of Schlemm's canal. In treated eyes, Schlemm's canal was 27% shorter (P = 0.02), and the length of the inner wall apparently available for fluid flow was 33% less (P = 0.001), both compared with paired control eyes.
CONCLUSIONS: TGF-beta2 reduces outflow facility when perfused into cultured human anterior segments. Furthermore, TGF-beta2 affects the extracellular matrix of the trabecular meshwork in a manner that is consistent with the observed reduction in outflow facility. Although the distribution of accumulated fibrillar material was different in these perfused eyes than that in POAG, the difference could be due to variation in biomechanical environment for TM cells in cultured anterior segments compared with the living eye. Overall, these results support the hypothesis that elevated TGF-beta2 levels in the aqueous humor play a role in the pathogenesis of the ocular hypertension in POAG.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14691167     DOI: 10.1167/iovs.03-0796

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  123 in total

1.  Cross-talk between miR-29 and transforming growth factor-betas in trabecular meshwork cells.

Authors:  Coralia Luna; Guorong Li; Jianming Qiu; David L Epstein; Pedro Gonzalez
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-01       Impact factor: 4.799

2.  In situ autofluorescence visualization of human trabecular meshwork structure.

Authors:  James C H Tan; Jose M Gonzalez; Sarah Hamm-Alvarez; Jonathan Song
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-24       Impact factor: 4.799

3.  Hic-5 Regulates Actin Cytoskeletal Reorganization and Expression of Fibrogenic Markers and Myocilin in Trabecular Meshwork Cells.

Authors:  Padmanabhan Paranji Pattabiraman; Ponugoti Vasantha Rao
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

4.  Myocilin levels in primary open-angle glaucoma and pseudoexfoliation glaucoma human aqueous humor.

Authors:  Kyle G Howell; Anne M Vrabel; Uttio Roy Chowdhury; William Daniel Stamer; Michael P Fautsch
Journal:  J Glaucoma       Date:  2010-12       Impact factor: 2.503

5.  Influence of race and age on aqueous humor levels of transforming growth factor-beta 2 in glaucomatous and nonglaucomatous eyes.

Authors:  Rupal H Trivedi; Matthew Nutaitis; David Vroman; Craig E Crosson
Journal:  J Ocul Pharmacol Ther       Date:  2010-10-29       Impact factor: 2.671

Review 6.  [Primary open angle glaucoma. Morphological bases for the understanding of the pathogenesis and effects of antiglaucomatic substances].

Authors:  E Lütjen-Drecoll; F E Kruse
Journal:  Ophthalmologe       Date:  2007-02       Impact factor: 1.059

Review 7.  Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.

Authors:  M Elizabeth Fini; Stephen G Schwartz; Xiaoyi Gao; Shinwu Jeong; Nitin Patel; Tatsuo Itakura; Marianne O Price; Francis W Price; Rohit Varma; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2016-09-22       Impact factor: 21.198

8.  Interleukin-6-mediated trans-signaling inhibits transforming growth factor-β signaling in trabecular meshwork cells.

Authors:  Miyuki Inoue-Mochita; Toshihiro Inoue; Sachi Kojima; Akiko Futakuchi; Tomokazu Fujimoto; Saori Sato-Ohira; Utako Tsutsumi; Hidenobu Tanihara
Journal:  J Biol Chem       Date:  2018-05-11       Impact factor: 5.157

Review 9.  The microfibril hypothesis of glaucoma: implications for treatment of elevated intraocular pressure.

Authors:  John Kuchtey; Rachel W Kuchtey
Journal:  J Ocul Pharmacol Ther       Date:  2014-02-12       Impact factor: 2.671

10.  RhoA GTPase-induced ocular hypertension in a rodent model is associated with increased fibrogenic activity in the trabecular meshwork.

Authors:  Padmanabhan P Pattabiraman; Tommy Rinkoski; Eric Poeschla; Alan Proia; Pratap Challa; Ponugoti V Rao
Journal:  Am J Pathol       Date:  2014-12-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.